Data Published in Nature Communications Demonstrate the Power of Fluidigm’s CyTOF and Imaging Mass Cytometry Technologies to Transform Cancer Drug Discovery and Enable New Precision Medicine Approaches in Clinical Oncology
Study Suggests Mass Cytometry Is a Valuable Tool for Predicting Individual Patient Response to TherapiesSOUTH SAN FRANCISCO, Calif., May 06,...